[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100628416":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":18,"centralContacts":24,"locations":33,"responsibleParty":102,"collaborators":104,"id":108,"slug":10,"hasResults":109,"nctId":110,"briefTitle":111,"officialTitle":112,"acronym":113,"eligibilityCriteria":114,"healthyVolunteers":109,"sex":115,"minAge":116,"maxAge":10,"enrollmentInfo":117,"targetDuration":120,"studyType":121,"phases":10,"briefSummary":122,"conditions":123,"keywords":125,"overallStatus":129,"whyStopped":10,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":134,"completionDateStruct":136,"leadSponsor":138,"locationsCount":139},{"fullName":5,"class":6},"University of California, San Francisco","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Current Stimulant Use",null,"Used stimulants (amphetamines, cocaine, etc.) in past year",{"label":13,"type":10,"description":14,"interventionNames":10},"Past Stimulant Use","Previously used stimulants (amphetamines, cocaine, etc.) but not in the last 12 months",{"label":16,"type":10,"description":17,"interventionNames":10},"No Stimulant use","Never used stimulants (amphetamines, cocaine, etc.)",[19,22],{"name":20,"affiliation":5,"role":21},"Phyllis Tien, MD","PRINCIPAL_INVESTIGATOR",{"name":23,"affiliation":5,"role":21},"Elise Riley, PhD",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Heather Freasier, MS, RD","CONTACT","415-683-9895","heather.freasier@ucsf.edu",{"name":31,"role":27,"phone":10,"phoneExt":10,"email":32},"Nneka Emenyonu, PhD","Nneka.Emenyonu@ucsf.edu",[34,48,65,84],{"facility":5,"status":10,"city":35,"state":36,"zip":37,"country":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"San Francisco","California","94115","United States",{"type":40,"coordinates":41},"Point",[42,43],-122.41942,37.77493,{"lat":43,"lon":42},[46,47],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},{"name":20,"role":21,"phone":10,"phoneExt":10,"email":10},{"facility":49,"status":10,"city":50,"state":51,"zip":52,"country":38,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Emory University, School of Medicine","Atlanta","Georgia","30322",{"type":40,"coordinates":54},[55,56],-84.38798,33.749,{"lat":56,"lon":55},[59,63],{"name":60,"role":27,"phone":61,"phoneExt":10,"email":62},"Rachael Farah-Abraham, PhD, MSc, CPH","404-251-8940","rachael.farah-abraham@emory.edu",{"name":64,"role":21,"phone":10,"phoneExt":10,"email":10},"Cecile Lahiri, MD",{"facility":66,"status":10,"city":67,"state":68,"zip":69,"country":38,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Johns Hopkins University","Baltimore","Maryland","21218",{"type":40,"coordinates":71},[72,73],-76.61219,39.29038,{"lat":73,"lon":72},[76,80,82],{"name":77,"role":27,"phone":78,"phoneExt":10,"email":79},"Jacquett Batson, MS, ITS","410-955-4912","jjohns20@jhu.edu",{"name":81,"role":21,"phone":10,"phoneExt":10,"email":10},"Todd Brown, MD",{"name":83,"role":21,"phone":10,"phoneExt":10,"email":10},"Katherine Wu, MD",{"facility":85,"status":10,"city":86,"state":87,"zip":88,"country":38,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"Albert Einstein College of Medicine","The Bronx","New York","10462",{"type":40,"coordinates":90},[91,92],-73.86641,40.84985,{"lat":92,"lon":91},[95,100],{"name":96,"role":27,"phone":97,"phoneExt":98,"email":99},"Janet Brown-Friday, RN, MSN, MPH","718-654-7099","2857","janet.brown@einsteinmed.edu",{"name":101,"role":21,"phone":10,"phoneExt":10,"email":10},"David Hannah, PhD",{"type":103,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[105],{"name":106,"class":107},"National Institute on Drug Abuse (NIDA)","NIH","100628416",false,"NCT07461350","Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV","Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV (SPISE)","SPISE","Inclusion Criteria:\n\n\\- Participants with and without HIV enrolled in the MACS\u002FWIHS Combined Cohort Study (MWCCS) Atlanta, Baltimore, Bronx, and San Francisco study sites\n\nExclusion Criteria:\n\n* Standard contraindications to MRI\n* claustrophobia,\n* metal implants,\n* large body size (weight \\>350 lbs or abdominal sagittal diameter \\>70 cm),\n* pregnancy)\n* Gadolinium risk\n* severe or uncontrolled asthma,\n* visit day eGFR\\\u003C45 ml\u002Fmin\u002F1.73 m2;\n* poor venous access\n* pregnancy or lactation","ALL","30 Years",{"count":118,"type":119},400,"ESTIMATED","1 Day","OBSERVATIONAL","This observational research study is studying how substance use impacts scarring and inflammation of the heart. This study involves one study visit for a cardiac MRI.",[124],"HIV (Human Immunodeficiency Virus)",[126,127,128],"HIV","cardiac MRI","stimulant use","NOT_YET_RECRUITING","2026-06-04",{"date":132,"type":133},"2026-06-05","ACTUAL",{"date":135,"type":119},"2026-06-22",{"date":137,"type":119},"2030-03-31",{"name":5,"class":6},4]